1-20 of 50187
Sort by
Image
Published: 25 April 2024
Graphical Abstract Graphical Abstract
Image
Published: 25 April 2024
Figure 1 Physiological measurements, experimental workflow, and proteome and phosphoproteome measurements. ( A ) Physiological measurements from CTRL and HF mice. Left: ejection fraction (EF; **** P < 0.0001, Mann–Whitney U test); middle: heart weight/tibia length (HW/TL; **** P < 0.0001, Mann–Whit
Image
Published: 25 April 2024
Figure 4 Linking local inflammation and macrophage expansion with SND in HF. ( A ) Sinus node proteome measurements from human subjects with HF as the cause of death ( n = 4) and human subjects without HF ( n = 3). Left, volcano plot shows log 2 transformed fold change of sinus node protein abundance in t
Image
Published: 25 April 2024
Figure 5 Linking local inflammation to electrical remodelling. ( A , left) Representative Galectin-3 western blot of sinus node biopsies SAN explants incubated in the absence (control) or presence (LPS) of 1 μg/mL LPS. Corresponding stain-free total protein gel used for quantification is shown in the lower p
Journal Article
Konstantin Kahnert and others
Cardiovascular Research, cvae054, https://doi.org/10.1093/cvr/cvae054
Published: 25 April 2024
Image
Published: 25 April 2024
Figure 2 Sinus node ion channel protein expression is reduced and recapitulates reduced heart rate. ( A ) Differential protein expression analysis. Volcano plot shows log 2 transformed fold change of protein abundances in HF compared to CTRL on the x -axis and −log 10 ( t -test P -value) on the y -axis.
Image
Published: 25 April 2024
Figure 3 Pharmacovigilance analysis and multi-omics data integration highlights proteins linked to bradycardic phenotype in humans. ( A ) Proteins significantly differentially expressed in the mouse HF with SND model which are also significantly associated with heart rate based on a resting heart rate GWAS o
Image
Published: 25 April 2024
Figure 6 Targeting galectin-3 signalling prevents SND in HF. ( A ) Experimental design for evaluating prevention of SND in TAC-induced HF by systemic galectin-3 targeting with MCP. ( B ) Effect of MCP treatment on the change in heart rate in vivo in HF. Left, mean ± S.E.M. (as well as individual data point
Journal Article
ACCEPTED MANUSCRIPT
Ljubica Matic and others
Cardiovascular Research, cvae089, https://doi.org/10.1093/cvr/cvae089
Published: 23 April 2024
Image
Published: 22 April 2024
Graphical Abstract Graphical Abstract
Journal Article
ACCEPTED MANUSCRIPT
Changsheng Chen and others
Cardiovascular Research, cvae085, https://doi.org/10.1093/cvr/cvae085
Published: 22 April 2024
Journal Article
ACCEPTED MANUSCRIPT
James A Coleman and others
Cardiovascular Research, cvae086, https://doi.org/10.1093/cvr/cvae086
Published: 22 April 2024
Image
Published: 22 April 2024
Graphical Abstract Graphical Abstract
Image
Published: 22 April 2024
Graphical Abstract Graphical Abstract
Journal Article
ACCEPTED MANUSCRIPT
Jingrui Chen and others
Cardiovascular Research, cvae084, https://doi.org/10.1093/cvr/cvae084
Published: 22 April 2024
Journal Article
ACCEPTED MANUSCRIPT
Guang-Jie Tai and others
Cardiovascular Research, cvae079, https://doi.org/10.1093/cvr/cvae079
Published: 21 April 2024
Image
Published: 21 April 2024
Graphical Abstract Graphical Abstract
Journal Article
ACCEPTED MANUSCRIPT
Jessa L Aldridge and others
Cardiovascular Research, cvae087, https://doi.org/10.1093/cvr/cvae087
Published: 20 April 2024
Journal Article
ACCEPTED MANUSCRIPT
Ryszard Nosalski and Matteo Lemoli
Cardiovascular Research, cvae076, https://doi.org/10.1093/cvr/cvae076
Published: 18 April 2024
Journal Article
ACCEPTED MANUSCRIPT
Min Hu and others
Cardiovascular Research, cvae077, https://doi.org/10.1093/cvr/cvae077
Published: 18 April 2024